<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>03965nam a22005655i 4500</leader>
  <controlfield tag="001">978-3-031-65948-5</controlfield>
  <controlfield tag="003">DE-He213</controlfield>
  <controlfield tag="005">20251030114638.0</controlfield>
  <controlfield tag="007">cr nn 008mamaa</controlfield>
  <controlfield tag="008">241225s2024    sz |    s    |||| 0|eng d</controlfield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">9783031659485</subfield>
    <subfield code="9">978-3-031-65948-5</subfield>
  </datafield>
  <datafield tag="024" ind1="7" ind2=" ">
    <subfield code="a">10.1007/978-3-031-65948-5</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="050" ind1=" " ind2="4">
    <subfield code="a">QH323.5</subfield>
  </datafield>
  <datafield tag="072" ind1=" " ind2="7">
    <subfield code="a">PBT</subfield>
    <subfield code="2">bicssc</subfield>
  </datafield>
  <datafield tag="072" ind1=" " ind2="7">
    <subfield code="a">MED090000</subfield>
    <subfield code="2">bisacsh</subfield>
  </datafield>
  <datafield tag="072" ind1=" " ind2="7">
    <subfield code="a">PBT</subfield>
    <subfield code="2">thema</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="0">
    <subfield code="a">Biostatistics in Biopharmaceutical Research and Development</subfield>
    <subfield code="h">[electronic resource] :</subfield>
    <subfield code="b">Clinical Trial Design, Volume 1 /</subfield>
    <subfield code="c">edited by Ding-Geng Chen.</subfield>
  </datafield>
  <datafield tag="250" ind1=" " ind2=" ">
    <subfield code="a">1st ed. 2024.</subfield>
  </datafield>
  <datafield tag="264" ind1=" " ind2="1">
    <subfield code="a">Cham :</subfield>
    <subfield code="b">Springer Nature Switzerland :</subfield>
    <subfield code="b">Imprint: Springer,</subfield>
    <subfield code="c">2024.</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">XXIV, 344 p. 118 illus.</subfield>
    <subfield code="b">online resource.</subfield>
  </datafield>
  <datafield tag="336" ind1=" " ind2=" ">
    <subfield code="a">text</subfield>
    <subfield code="b">txt</subfield>
    <subfield code="2">rdacontent</subfield>
  </datafield>
  <datafield tag="337" ind1=" " ind2=" ">
    <subfield code="a">computer</subfield>
    <subfield code="b">c</subfield>
    <subfield code="2">rdamedia</subfield>
  </datafield>
  <datafield tag="338" ind1=" " ind2=" ">
    <subfield code="a">online resource</subfield>
    <subfield code="b">cr</subfield>
    <subfield code="2">rdacarrier</subfield>
  </datafield>
  <datafield tag="347" ind1=" " ind2=" ">
    <subfield code="a">text file</subfield>
    <subfield code="b">PDF</subfield>
    <subfield code="2">rda</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2=" ">
    <subfield code="a">Bias and Randomization in Clinical Trials: 1980s &#x2013; 2020s &#x2013; 2060s -- The Markov Model for Survival Trials at 35 Years-Old -- Absolute Power Corrupts Absolutely: A Review of the Use of Unconditional Probabilities in the Planning of Clinical Trials -- Design of Clinical Trials with the Desirability of Outcome Ranking Methodology -- Benefit:Risk Assessments during Clinical Trials: A Prediction Approach Using the Desirability of Outcome Ranking (DOOR) -- The Power of Integration: How the 2-in-1 Clinical Trial Design is Changing the Future of Drug Development -- A Unified Bayesian Decision Rule-Based Approach for Bayesian Design of Clinical Trials Using Historical Data -- Group Sequential Design Under Non-proportional Hazards: Methodologies and Examples -- Multiple Testing in Group Sequential Design -- Plan per-protocol (PP) causal inference analysis addressing intercurrent events following the targeted learning roadmap -- Maximum Tolerated Imbalance Randomization: Theory and Practice -- Response-adaptive randomization designs based on optimal allocation proportion.</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">The Deming Conference on Applied Statistics has long been deemed an influential event in the biostatistics and biopharmaceutical profession. It provides learning experience on recent developments in statistical methodologies in biopharmaceutical applications and FDA regulations. This book honors 80 years of contributions and dedication of the Deming Conference in biostatistics, and biopharmaceutical clinical trial methodology and applications. All chapters are contributed by world-class and prominent Deming speakers, who've contributed their cutting-edge research and developments to the community. Volume 1 covers Historical Milestones in Clinical Trial Design, FDA biopharmaceutical design guidance, and emerging development in Clinical Trial Design Methodology. This book aims to booster research, education, and training in biostatistics and in biopharmaceutical research and development.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Biometry.</subfield>
    <subfield code="9">65981</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Clinical medicine</subfield>
    <subfield code="x">Research.</subfield>
    <subfield code="9">74123</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Public health.</subfield>
    <subfield code="9">61312</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Sampling (Statistics).</subfield>
    <subfield code="9">59805</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="0">
    <subfield code="a">Data mining.</subfield>
    <subfield code="9">6941</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="4">
    <subfield code="a">Biostatistics.</subfield>
    <subfield code="9">65985</subfield>
  </datafield>
  <datafield tag="650" ind1="2" ind2="4">
    <subfield code="a">Clinical Research.</subfield>
    <subfield code="9">74124</subfield>
  </datafield>
  <datafield tag="650" ind1="2" ind2="4">
    <subfield code="a">Public Health.</subfield>
    <subfield code="9">61312</subfield>
  </datafield>
  <datafield tag="650" ind1="2" ind2="4">
    <subfield code="a">Survey Methodology.</subfield>
    <subfield code="9">74358</subfield>
  </datafield>
  <datafield tag="650" ind1="2" ind2="4">
    <subfield code="a">Data Mining and Knowledge Discovery.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Chen, Ding-Geng.</subfield>
    <subfield code="e">editor.</subfield>
    <subfield code="4">edt</subfield>
    <subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield>
    <subfield code="9">80220</subfield>
  </datafield>
  <datafield tag="710" ind1="2" ind2=" ">
    <subfield code="a">SpringerLink (Online service)</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
    <subfield code="t">Springer Nature eBook</subfield>
  </datafield>
  <datafield tag="776" ind1="0" ind2="8">
    <subfield code="i">Printed edition:</subfield>
    <subfield code="z">9783031659478</subfield>
  </datafield>
  <datafield tag="776" ind1="0" ind2="8">
    <subfield code="i">Printed edition:</subfield>
    <subfield code="z">9783031659492</subfield>
  </datafield>
  <datafield tag="776" ind1="0" ind2="8">
    <subfield code="i">Printed edition:</subfield>
    <subfield code="z">9783031659508</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
    <subfield code="u">https://doi.org/10.1007/978-3-031-65948-5</subfield>
  </datafield>
  <datafield tag="912" ind1=" " ind2=" ">
    <subfield code="a">ZDB-2-SME</subfield>
  </datafield>
  <datafield tag="912" ind1=" " ind2=" ">
    <subfield code="a">ZDB-2-SXM</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">66021</subfield>
    <subfield code="d">66021</subfield>
  </datafield>
</record>
